ReviewLife (Basel, Switzerland)2023

Update on the Management of Diabetic Retinopathy: Anti-VEGF Agents for the Prevention of Complications and Progression of Nonproliferative and Proliferative Retinopathy.

Tyler A Bahr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.